AVITA Medical, Inc. Debt Securities, Available-for-sale, Amortized Cost, Noncurrent
AVITA Medical, Inc. (RCEL) had Debt Securities, Available-for-sale, Amortized Cost, Noncurrent of $2.76 million as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Notes › Credit Losses
us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent · last filed 2024-02-22
- 2023-06-30: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $2.76M.
- 2023-03-31: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $4.19M.
- 2022-12-31: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $6.93M.
- 2022-09-30: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $4.05M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost, Noncurrent |
|---|---|
| 2023-06-30 | $2.76M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $4.19M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.93M 10-K · filed 2024-02-22 |
| 2022-09-30 | $4.05M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $6.92M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $11.92M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $19.79M 10-K · filed 2023-02-23 |
| 2021-09-30 | $19.81M 10-Q · filed 2021-11-08 |